These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30763392)

  • 81. Mammotome biopsy under ultrasound control in the diagnostics and treatment of nodular breast lesions - own experience.
    Kibil W; Hodorowicz-Zaniewska D; Kulig J
    Pol Przegl Chir; 2012 May; 84(5):242-6. PubMed ID: 22763299
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Core biopsies of the breast: diagnostic pitfalls.
    Joshi M; Reddy SJ; Nanavidekar M; Russo JP; Russo AV; Pathak R
    Indian J Pathol Microbiol; 2011; 54(4):671-82. PubMed ID: 22234089
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue.
    Happerfield LC; Miles DW; Barnes DM; Thomsen LL; Smith P; Hanby A
    J Pathol; 1997 Dec; 183(4):412-7. PubMed ID: 9496257
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Topoisomerase II alpha expression and the Ki-67 labeling index correlate with prognostic factors in estrogen receptor-positive and human epidermal growth factor type-2-negative breast cancer.
    Tokiniwa H; Horiguchi J; Takata D; Kikuchi M; Rokutanda N; Nagaoka R; Sato A; Odawara H; Tozuka K; Oyama T; Takeyoshi I
    Breast Cancer; 2012 Oct; 19(4):309-14. PubMed ID: 21725655
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
    Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
    Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Immunohistochemistry subtypes (ER/PR/HER) of breast cancer: where do we stand in the West of Saudi Arabia?
    Khabaz MN
    Asian Pac J Cancer Prev; 2014; 15(19):8395-400. PubMed ID: 25339035
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Advancing cancer diagnostics with artificial intelligence and spectroscopy: identifying chemical changes associated with breast cancer.
    Talari ACS; Rehman S; Rehman IU
    Expert Rev Mol Diagn; 2019 Oct; 19(10):929-940. PubMed ID: 31461624
    [No Abstract]   [Full Text] [Related]  

  • 88. Subsurface probing of calcifications with spatially offset Raman spectroscopy (SORS): future possibilities for the diagnosis of breast cancer.
    Stone N; Baker R; Rogers K; Parker AW; Matousek P
    Analyst; 2007 Sep; 132(9):899-905. PubMed ID: 17710265
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Serum Raman spectroscopy combined with multiple classification models for rapid diagnosis of breast cancer.
    Li H; Wang S; Zeng Q; Chen C; Lv X; Ma M; Su H; Ma B; Chen C; Fang J
    Photodiagnosis Photodyn Ther; 2022 Dec; 40():103115. PubMed ID: 36096439
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Raman spectroscopy and machine learning for the classification of breast cancers.
    Zhang L; Li C; Peng D; Yi X; He S; Liu F; Zheng X; Huang WE; Zhao L; Huang X
    Spectrochim Acta A Mol Biomol Spectrosc; 2022 Jan; 264():120300. PubMed ID: 34455388
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Depth profiling of calcifications in breast tissue using picosecond Kerr-gated Raman spectroscopy.
    Baker R; Matousek P; Ronayne KL; Parker AW; Rogers K; Stone N
    Analyst; 2007 Jan; 132(1):48-53. PubMed ID: 17180179
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Accurate identification of breast cancer margins in microenvironments of ex-vivo basal and luminal breast cancer tissues using Raman spectroscopy.
    Koya SK; Brusatori M; Yurgelevic S; Huang C; Werner CW; Kast RE; Shanley J; Sherman M; Honn KV; Maddipati KR; Auner GW
    Prostaglandins Other Lipid Mediat; 2020 Dec; 151():106475. PubMed ID: 32711127
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Indication of high lipid content in epithelial-mesenchymal transitions of breast tissues.
    Sabtu SN; Sani SFA; Looi LM; Chiew SF; Pathmanathan D; Bradley DA; Osman Z
    Sci Rep; 2021 Feb; 11(1):3250. PubMed ID: 33547362
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Potential for Raman spectroscopy to provide cancer screening using a peripheral blood sample.
    Harris AT; Lungari A; Needham CJ; Smith SL; Lones MA; Fisher SE; Yang XB; Cooper N; Kirkham J; Smith DA; Martin-Hirsch DP; High AS
    Head Neck Oncol; 2009 Sep; 1():34. PubMed ID: 19761601
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Comparison of autofluorescence, diffuse reflectance, and Raman spectroscopy for breast tissue discrimination.
    Majumder SK; Keller MD; Boulos FI; Kelley MC; Mahadevan-Jansen A
    J Biomed Opt; 2008; 13(5):054009. PubMed ID: 19021389
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Group and Basis Restricted Non-Negative Matrix Factorization and Random Forest for Molecular Histotype Classification and Raman Biomarker Monitoring in Breast Cancer.
    Deng X; Milligan K; Ali-Adeeb R; Shreeves P; Brolo A; Lum JJ; Andrews JL; Jirasek A
    Appl Spectrosc; 2022 Apr; 76(4):462-474. PubMed ID: 34355582
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Metabolite profiling of human blood by surface-enhanced Raman spectroscopy for surgery assessment and tumor screening in breast cancer.
    Lin D; Wang Y; Wang T; Zhu Y; Lin X; Lin Y; Feng S
    Anal Bioanal Chem; 2020 Mar; 412(7):1611-1618. PubMed ID: 31965246
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Raman spectroscopy for esophageal tumor diagnosis and delineation using machine learning and the portable Raman spectrometer.
    Yang J; Xu P; Wu S; Chen Z; Fang S; Xiao H; Hu F; Jiang L; Wang L; Mo B; Ding F; Lin LL; Ye J
    Spectrochim Acta A Mol Biomol Spectrosc; 2024 Sep; 317():124461. PubMed ID: 38759393
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Application of serum Raman spectroscopy combined with classification model for rapid breast cancer screening.
    Lin R; Peng B; Li L; He X; Yan H; Tian C; Luo H; Yin G
    Front Oncol; 2023; 13():1258436. PubMed ID: 37965448
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The potential for histological screening using a combination of rapid Raman mapping and principal component analysis.
    Hutchings J; Kendall C; Smith B; Shepherd N; Barr H; Stone N
    J Biophotonics; 2009 Feb; 2(1-2):91-103. PubMed ID: 19343688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.